Enzyme treated bcg vaccine and process therefor

Details Enzyme treated bcg vaccine and process therefor Enzyme treated bcg vaccine and process therefor

A - Human Necessities

61

K

A61K 39/04 (2006.01)

Patent

CA 2073778

Mycobacterium bovis BCG suspensions are treated with a protease enzyme such as pronase, resulting in the production of suspensions having smaller aggregates and single cells. Such suspensions, when processed into vaccines, exhibit improved immunizing potential against cancer and would be expected to exhibit improved immunizing potential against tuberculosis.

On traite des suspensions de Mycobacterium bovis BCG à l'aide d'une enzyme de protéase telle que la pronase, ayant pour résultat la production de suspensions présentant des agrégats plus petits et des cellules individuelles. Ladite suspension, une fois traitée pour obtenir des vaccins, présente un potentiel immunisant amélioré contre le cancer, et on pense qu'elle présente un potentiel immunisant amélioré contre la tuberculose.

Affiliated with

Also associated with

Rating

Enzyme treated bcg vaccine and process therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enzyme treated bcg vaccine and process therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enzyme treated bcg vaccine and process therefor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1957950